|
2. Etiologie
|
|
|
Am I more likely to get cancer because I'm tall? [BBC News]
|
|
|
|
|
|
Tim
Cole, a professor of medical statistics at University College London,
says there's no need for tall people to worry - especially as increased
height normally means you're less likely to get other conditions, such
as heart disease. "Being taller suggests you've had a better experience,
a more healthy experience in childhood," he says.
|
|
|
|
|
|
|
3.1 Tabac
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.2 Pharma
|
|
|
Artificial Intelligence, You Say? [In the Pipeline]
|
|
|
|
|
|
Their
approach is ambitious, although certainly not crazy, but they’re going
to want to keep an eye on their press coverage. Talking up “artificial
intelligence” and “cutting development times in half” may bring them a
bit more notoriety than is needed.
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
|
5.2.3 Pharma - économie
|
|
|
Pfizer's CEO Faces The Drug Pricing Firestorm [Forbes]
|
|
|
|
|
|
A
bigger question is whether Ibrance is too expensive. It costs $118,000
per patient per year, and other cancer drugs, like Merck’s Keytruda and
Amgen’s Blincyto, cost more. One drug combination from Bristol-Myers
Squibb for melanoma can cost $256,000 per patient. “I understand the
physicians saying, ‘Look, these prices are too high,’ ” Read says. “
It’s because their patients can’t get access. That is an insurance
issue.”
|
|
|
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
Four Reasons Drugs Are Expensive, Of Which Two Are False [Forbes]
|
|
|
|
|
|
When
Jack Scannell, the guy who coined the term “Eroom’s Law” (Moore’s Law
backwards) to describe the exponential increase in the cost of
developing a new drug between 1950 and 2010, tells you he wants to tell
you everything he thinks about drug prices, you listen.
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
ASCO Introduces New Online Genetics Toolkit [ASCO]
|
|
|
|
|
|
The
Genetics Toolkit offers a wide range of resources, including
information on the characteristics of hereditary cancer risk, assessing a
patients’ hereditary risk, understanding panel tests and genetic
testing results, using risk assessment models, and other aspects of
incorporating clinical cancer genetics into cancer treatment and
management plans.
|
|
|
|
|
|
|
|
|
6.1 Observation
|
|
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
6.9 Controverses
|
|
|
Most animal research studies may not avoid key biases [Science]
|
|
|
|
|
|
Researchers
who conduct animal studies often don't use simple safeguards against
biases that have become standard in human clinical trials—or at least
they don't report doing so in their scientific papers, making it
impossible for readers to ascertain the quality of the work, an analysis
of more than 2500 journal articles shows.
|
|
|
|
|
|
|